Surreal illustration balancing nutrition and medical intervention in pancreatic cancer treatment.

Boosting Immunity in Pancreatic Cancer Patients: Can Diet Make a Difference?

Rhea Morgan monogram
Rhea Morgan in Health & Wellness October 2026 • 5 min read.

"Explore how targeted nutrition, including immune-enhancing diets, can help counteract the negative effects of surgery and malnutrition in pancreatic cancer treatment."


Pancreatic cancer surgery is a highly invasive procedure often leading to complications due to extensive tissue damage and malnutrition, which can weaken the immune system, making patients more vulnerable to infections. Addressing these immune system deficiencies through targeted nutrition strategies, such as immunonutrition, is emerging as a promising approach to improve patient outcomes after surgery.

Immunonutrition involves using specialized diets enriched with specific nutrients that support and enhance immune function. While the potential benefits are recognized, the precise mechanisms by which these diets work to regulate the immune system, particularly in the context of pancreatic cancer and surgery, remain an area of active research.

A study investigated the effects of surgical trauma and immunonutrition on key components of the immune system. The research focused on how these factors influence apoptosis—a process of programmed cell death—in lymphocytes (a type of white blood cell) and the overall immune response in patients undergoing surgery for pancreatic cancer.

AI Search Multiple angles on this topic

Evidence on Perioperative Immunonutrition

Research on immunonutrition in pancreatic cancer has examined its use around surgery and its potential effects on postoperative outcomes. A randomized controlled trial focused on preoperative oral immunonutrition and complications and hospital length of stay after elective pancreatic cancer surgery. A 2020 systematic review and meta-analysis assessed postoperative outcomes and immune-system effects, while noting that the effects and mechanisms remained unclear. The supplied material does not report outcome figures or current patient statistics. (Reference URL 1; Reference URL 2)

From Surgical Nutrition to Prehabilitation

Immunonutrition is defined as the use of special nutritional substrates, or immunonutrients, to regulate nutritional status and immune and inflammatory functions. In pancreatic cancer surgery, available studies have supported preoperative oral immunonutrition as a possible way to reduce postoperative infections and hospital length of stay, although further well-designed studies are needed to confirm the evidence. More recent work places nutrition within prehabilitation: patients may be physically and nutritionally debilitated while facing chemotherapy, chemoradiation, and surgery, making physical, nutritional, and psychosocial support relevant to treatment tolerance. The 2020 systematic review also emphasized that the effects and mechanisms of immunonutrition remained unclear. (Reference URL 1; Reference URL 2)

How Immunonutrition Impacts the Immune System After Pancreatic Cancer Surgery

Surreal illustration balancing nutrition and medical intervention in pancreatic cancer treatment.

The study closely examined how surgical trauma and specific nutritional interventions affected the delicate balance of apoptotic signaling pathways in lymphocytes. These pathways are crucial for regulating immune responses, and any disruption can significantly impact a patient's susceptibility to infections and overall recovery. By understanding these changes, healthcare professionals can better tailor nutritional support to optimize immune function.

Researchers assessed the expression of specific proteins—TNFRI/CD120a, Fas/CD95, and Bcl-2—in lymphocytes. These proteins play key roles in the apoptotic process. Measurements were taken before surgery and at various points afterward (days 1, 3, and 7) to track changes in their levels. Patients were randomly assigned to receive either a standard enteral diet or an immune-enhancing enteral diet before surgery.

  • TNFRI/CD120a and Fas/CD95: These proteins promote apoptosis (cell death). The study found that the percentage of lymphocytes expressing these proteins was significantly higher in pancreatic cancer patients compared to a control group, both before and after surgery.
  • Bcl-2: This protein inhibits apoptosis, helping cells survive. Researchers observed a significant decrease in Bcl-2-positive lymphocytes after surgery, indicating increased cell death.
  • Immunonutrition Effects: Preoperative immunonutrition significantly increased the percentage of CD95 and TNFRI positive lymphocytes after surgery, suggesting a potential boost in pro-apoptotic signaling.
AI Search Multiple angles on this topic

Brucea javanica Oil-Liposome Cell Study

The listed basic research study examined Brucea javanica oil-loaded liposomes (BJOL) in human hepatocellular cancer cells. It assessed cell proliferation after treatment with different BJOL doses using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. The supplied description concerns hepatocellular cancer cells and does not report findings in pancreatic cancer patients or dietary effects. doi.org

Enteral and Parenteral Nutrition Findings

One source describes measurements of aluminum in 12 enteral nutrition formulas and 10 parenteral solutions used in routine clinical care and obtained from medical companies in Turkey. A separate source reports that the EPaNIC study found an advantage in discharges alive from the ICU when parenteral nutrition was delayed until day 8, compared with combining enteral and parenteral nutrition from day 3 of the ICU stay. These sources address formula composition and ICU nutrition timing, respectively; the supplied material does not establish a direct comparison between those topics or a pancreatic-cancer-specific result. (Reference URL 1; Reference URL 2)

The findings suggest that immunonutrition can modulate apoptotic signaling pathways in malnourished patients undergoing pancreatic cancer surgery. This modulation could help counteract the immune suppression often seen after surgery, potentially improving patient outcomes. However, the study also points to the need for careful consideration of the potential pro-apoptotic effects, ensuring that interventions are appropriately targeted to maximize benefits without unintended consequences.

Looking Ahead: Optimizing Nutritional Strategies for Pancreatic Cancer Patients

This research sheds light on the intricate relationship between surgical trauma, malnutrition, and immune function in pancreatic cancer patients. The study highlights the potential of immunonutrition to influence apoptotic signaling pathways and modulate the immune response after surgery.

AI Search Multiple angles on this topic

Further Study of Immunonutrition in Pancreatic Surgery

The supplied review describes nutrition and nutritional adjuncts as areas of particular interest in pancreatic cancer, given advanced disease and physiologically strenuous complications. It reports that several meta-analyses have found marked benefits from implementing immunonutrition in patients undergoing pancreatic surgery. This supports continued investigation of immunonutrition in that surgical setting, while the supplied material does not specify particular future trials or quantify the reported benefits. surgonc.theclinics.com

While the findings are promising, questions remain about the precise anti-apoptotic effects of immunonutrition in this specific patient population. The need for further research is clear. Future studies should explore how different immunonutrients affect apoptotic signaling proteins, allowing for the development of more refined and effective nutritional strategies.

By continuing to investigate and optimize nutritional interventions, healthcare professionals can strive to improve immune function, reduce complications, and ultimately enhance the quality of life for individuals undergoing treatment for pancreatic cancer. A personalized approach to nutrition, tailored to the specific needs and immune status of each patient, may hold the key to unlocking even greater benefits.

What immune measurements and infection outcomes show

The study card describes measurements of cell-death signaling proteins in lymphocytes, while other cited work reports infection outcomes. These are different kinds of evidence: the signaling measurements do not show whether changes in those proteins correspond to fewer infections.[1] [2]

A separate study found higher early postoperative levels of an inflammation-regulating marker with enteral immunonutrition than with standard nutrition. Taken together, these findings describe immune and inflammatory responses, but do not establish that one measured response caused another or determined a patient's outcome.[3]

How immune response findings relate to surgical outcomes

Another review reported lower infectious complications in the immunonutrition group, while a separate study reported higher early postoperative IL-1ra concentrations with enteral immunonutrition than with standard diet. These outcome and marker findings are not interchangeable with measurements of lymphocyte signaling.[2] [3]

Malnutrition-related lymphocyte changes and tissue trauma are described as factors associated with susceptibility to infection; surgical resection is also described as adding oxidative and inflammatory stress and depleting antioxidants and nutrients. This context helps explain why immune markers and clinical outcomes are both studied, without linking them directly in these findings.[1] [4] [5]

What remains unresolved about immune changes

  • Would comparisons by nutritional status or by the specific immunonutrition used produce different findings?[6]

Sources

  1. Aktywacja proapoptotycznych szlaków sygnałowych w limfocytach krwi obwodowej niedożywionych chorych na raka trzustki po przedoperacyjnym dojelitowym żywieniu wspomagającym odporność (immunonutrition), (doi.org, 2011)
  2. Value of immunonutrition in patients undergoing pancreatic resection: a trial sequential meta-analysis. (pubmed.ncbi.nlm.nih.gov)
  3. Can the interleukin-1 receptor antagonist (IL-1ra) be a marker of anti-inflammatory response to enteral immunonutrition in malnourished patients after pancreaticoduodenectomy? (pubmed.ncbi.nlm.nih.gov)
  4. Should perioperative immunonutrition for elective surgery be the current standard of care? (pmc.ncbi.nlm.nih.gov)
  5. Preoperative immunonutrition as a strategy for reducing oxidative stress and inflammation in pancreatic ductal adenocarcinoma (pmc.ncbi.nlm.nih.gov)
  6. Impact of perioperative immunonutrition on postoperative outcomes in pancreaticoduodenectomy: a systematic review and meta-analysis of randomized controlled trials (pmc.ncbi.nlm.nih.gov)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.5114/pg.2011.22800, Alternate LINK

Title: The Up-Regulation Of Pro-Apoptotic Signalling Systems In Peripheral Blood Lymphocytes Of Malnourished Patients With Pancreatic Cancer After Preoperative Enteral Immune-Enhancing Diet ( Immunonutrition )

Subject: Gastroenterology

Journal: Gastroenterology Review

Publisher: Termedia Sp. z.o.o.

Authors: Robert Słotwiński, Waldemar L. Olszewski, Maciej Słodkowski, Gustaw Lech, Marzanna Zaleska, Sylwia Kędziora, Sylwia M. Słotwińska

Published: 2011-01-01

Everything You Need To Know

1

What exactly is immunonutrition and why is it used?

Immunonutrition involves the use of specialized diets that are enriched with specific nutrients. These diets are designed to support and enhance immune function. This approach is particularly relevant for pancreatic cancer patients undergoing surgery who often experience malnutrition and weakened immune systems. The goal is to counteract the negative effects of surgery and improve patient outcomes by boosting the body's ability to fight infections and heal.

2

Why is the process of apoptosis important in this context?

The significance of apoptosis lies in its impact on the immune system's ability to function effectively, especially after pancreatic cancer surgery. Apoptosis is programmed cell death, and the balance of apoptotic signaling pathways in lymphocytes directly affects a patient's susceptibility to infections and their overall recovery. Specifically, the study examined the expression of proteins like TNFRI/CD120a, Fas/CD95, and Bcl-2, which regulate apoptosis. Understanding these changes allows healthcare professionals to tailor nutritional support, like immunonutrition, to optimize immune function.

3

Why did the researchers investigate TNFRI/CD120a, Fas/CD95, and Bcl-2?

The study investigated the proteins TNFRI/CD120a, Fas/CD95, and Bcl-2, because they are key regulators of apoptosis in lymphocytes. TNFRI/CD120a and Fas/CD95 promote cell death, while Bcl-2 inhibits it. The researchers measured the levels of these proteins before and after surgery in patients receiving either a standard enteral diet or an immune-enhancing enteral diet. The findings revealed how immunonutrition affects these pathways, potentially improving immune response post-surgery in patients with pancreatic cancer.

4

What impact did immunonutrition have on the study?

Immunonutrition, in the context of this research, showed a potential to modulate apoptotic signaling pathways in malnourished patients undergoing pancreatic cancer surgery. It increased the percentage of CD95 and TNFRI positive lymphocytes after surgery. This suggests a potential boost in pro-apoptotic signaling, which could help counteract the immune suppression often seen after surgery. However, the study also points to the need for careful consideration to maximize benefits without unintended consequences.

5

Why is malnutrition a significant problem for these patients?

Malnutrition is a critical issue in pancreatic cancer patients, especially those undergoing surgery, because it weakens the immune system and increases vulnerability to infections. Surgery itself causes significant tissue damage, further contributing to immune deficiencies. Immunonutrition addresses malnutrition by providing targeted nutritional support, which aims to enhance immune function. By improving the immune response, immunonutrition can lead to better recovery outcomes and overall health for these patients.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.